Cite
HARVARD Citation
Aw, A. et al. (2018). Minimal residual disease detected by immunoglobulin sequencing predicts CLL relapse more effectively than flow cytometry. Leukemia & lymphoma. 59 (8), pp. 1986-1989. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Aw, A. et al. (2018). Minimal residual disease detected by immunoglobulin sequencing predicts CLL relapse more effectively than flow cytometry. Leukemia & lymphoma. 59 (8), pp. 1986-1989. [Online].